Obvious American buys in the stock market

While to dollar continues to flirt with parity, it might be a good time to be shopping for shares in the US

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sometimes, we overthink.

For those of us who spend our lives scouring the stock market for great deals, there's often a bias toward uncovering the next big thing or championing the fallen angel. In the worst cases, we can become the anti-Peter Lynch and end up "buying what we don't know."

So today, I want to highlight five obvious, rock-solid companies that are trading for reasonable-to-low price multiples. In other words, good stocks at good prices that I think can beat the Dow Jones and the S&P 500.

Let's start off in the retail space for our first two. As we move increasingly to an e-commerce-driven society, there's a tendency to pooh-pooh anything bricks-and-mortar because of Amazon.com (Nasdaq: AMZN). The result is unfairly cheap prices for many retailers. I do think specialty retailers Best Buy and RadioShack have been beaten down unfairly and have bought shares myself, but they're closer to fallen angels than rock-solid businesses. Instead, let me point out Wal-Mart (NYSE: WMT) and Target (NYSE: TGT) . When I look at any other retailer, I think to myself, "Can it compete successfully with Wal-Mart, Target, and Amazon?" Usually, the answer is "No."

They define a convenient, real-time one-stop shopping experience. Unless shipping becomes instantaneous versus next-day, Wal-Mart and Target will continue to have allure. And, if you're like me, once you're there, you're loading up your cart.

Each holds moderate debt, leading to returns on equity around 20%, and each trades for 12 times next year's earnings estimates.

Now, what value investor's list of obvious buys would be complete without mentioning Warren Buffett's Berkshire Hathaway? I won't belabor the point, because it's well-worn ground. Think of Buffett's sprawling conglomerate as a mutual fund carefully constructed by the world's greatest investor. Buffett wants the company to be his legacy, so you can imagine the care he's taking to make sure his baby is built for the long haul. Last year, shares were trading so low that Buffett got the Berkshire board to approve an unprecedented potential action. When shares trade down to 1.1 times book value, Berkshire may now buy its own stock back. Shares trade at a smidge over 1.2 now. Not as low as Buffett's magic number, but still an obvious buy.

Speaking of mutual funds, Johnson & Johnson (NYSE:  JNJ) is known as a de facto health-care mutual fund. J&J dominates in medical devices, prescriptions, and the famous consumer goods such as Band-Aids and Tylenol. And unlike the health-care insurers, J&J will be strong regardless of just about any future regulatory scenario.

Looking long-term, I also don't believe that recent product recalls or negative legal results will significantly impair the juggernaut's prospects. J&J is trading for less than 15 times average earnings and free cash flow for the past five years and a dividend yield of 3.5%, and I continue to happily hold my shares.

Moving on to tech, it's fun to bash Microsoft. It's the big, lumbering bully to Apple's splashy it-boy. All of us cubicle dwellers complain about Windows and Office, laugh at Google's dominance over Bing in search, and perhaps defect to Chrome or Firefox over Internet Explorer. And let's not even talk about Microsoft's forays into mobile.

We can make fun all we want, but cutting away the comedy, Microsoft's Windows and Office cash cows have remained dominant and Microsoft hasn't been dying. It's been growing earnings per share at an 18.6% annual clip over the past five years. That's growth-stock-worthy. But factoring in its net cash, it's trading at less than 8 times free cash flow. Add in a 2.7% dividend yield, and Microsoft is looking mighty tasty.

I think that at today's prices, Wal-Mart, Target, Berkshire Hathaway, J&J, and Microsoft are solid businesses that are obvious buys.

More reading

The Motley Fool's purpose is to help the world invest, better. Take Stock is The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

A version of this article was originally published on fool.com

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »